» Articles » PMID: 30281956

Unsupervised Cluster Analysis of Chronic Rhinosinusitis with Nasal Polyp Using Routinely Available Clinical Markers and Its Implication in Treatment Outcomes

Overview
Date 2018 Oct 4
PMID 30281956
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multidimensional disease. In this study, we performed an unsupervised cluster analysis of CRSwNP using routinely available clinical markers.

Methods: We conducted a retrospective review of patients treated with endoscopic sinus surgery due to medically intractable bilateral CRSwNP from 2009 to 2017. Unsupervised cluster analysis was performed using a patient's clinical features, including age, peripheral blood eosinophil, tissue eosinophilia, Lund-Mackay computed tomography (CT) scores, ratio of the CT scores for the ethmoid sinus and maxillary sinus (E/M ratio), and comorbid asthma. Tree analysis was performed to develop a clustering algorithm. Kaplan-Meier survival analysis was performed to determine the revision surgery-free probability corresponding to each cluster.

Results: Data were available on 375 patients. Patients were categorized into 6 clusters comprising 2 asthmatic clusters and 4 non-asthmatic clusters. The labels for the 2 asthmatic clusters were: asthmatic non-eosinophilic polyp (cluster A1) and asthmatic eosinophilic polyp (cluster A2). The labels for the 4 non-asthmatic clusters were: non-eosinophilic polyp with older age (cluster NA1); non-eosinophilic pol'yp with younger age (cluster NA2); eosinophilic polyp with lower E/M ratio (cluster NA3); and eosinophilic polyp with higher E/M ratio (cluster NA4). The 4-year revision-free rates were 100% (cluster NA1), 80.3% (NA2), 98.0% (NA3), 66.7% (NA4), 100% (A1), and 66.7% (A2). The clusters showed statistically significant differences in terms of 4-year revision-free rates (log-rank p < 0.05).

Conclusion: Cluster analysis identified 2 asthmatic clusters and 4 non-asthmatic clusters in CRSwNP. Each cluster corresponded to a different clinical outcome.

Citing Articles

Differences in Clinical and Immunological Characteristics According to the Various Criteria for Tissue Eosinophilia in Chronic Rhinosinusitis With Nasal Polyps.

Yang S, Kim J, Won T, Rhee C, Han Y, Cho S Clin Exp Otorhinolaryngol. 2023; 16(4):359-368.

PMID: 37641857 PMC: 10710925. DOI: 10.21053/ceo.2023.00542.


A Scoping Review of Artificial Intelligence Research in Rhinology.

Osie G, Darbari Kaul R, Alvarado R, Katsoulotos G, Rimmer J, Kalish L Am J Rhinol Allergy. 2023; 37(4):438-448.

PMID: 36895144 PMC: 10273866. DOI: 10.1177/19458924231162437.


The Evolution and Application of Artificial Intelligence in Rhinology: A State of the Art Review.

Amanian A, Heffernan A, Ishii M, Creighton F, Thamboo A Otolaryngol Head Neck Surg. 2022; 169(1):21-30.

PMID: 35787221 PMC: 11110957. DOI: 10.1177/01945998221110076.


Age related non-type 2 inflammation and its association with treatment outcome in patients with chronic rhinosinusitis with nasal polyp in Korea.

Kim J, Won T, Woo H, Yang S, Phannikul C, Ko S Sci Rep. 2022; 12(1):1671.

PMID: 35102253 PMC: 8803874. DOI: 10.1038/s41598-022-05614-z.


IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain.

Fernandes M, Schelotto M, Doldi P, Milani G, Manzano A, Perera Valdivia D F1000Res. 2021; 10:42.

PMID: 33732434 PMC: 7885290. DOI: 10.12688/f1000research.27809.1.